SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $26,038,000 | +20.4% | 266,963 | +14.5% | 0.01% | +14.3% |
| Q4 2014 | $21,628,000 | +30.2% | 233,084 | -3.5% | 0.01% | +40.0% |
| Q3 2014 | $16,608,000 | -37.1% | 241,476 | -4.2% | 0.01% | -37.5% |
| Q2 2014 | $26,424,000 | +24.2% | 252,139 | -1.6% | 0.01% | +14.3% |
| Q1 2014 | $21,269,000 | +20.7% | 256,345 | -5.9% | 0.01% | +16.7% |
| Q4 2013 | $17,627,000 | +11.0% | 272,356 | +8.7% | 0.01% | 0.0% |
| Q3 2013 | $15,880,000 | +98.7% | 250,515 | +31.6% | 0.01% | +100.0% |
| Q2 2013 | $7,993,000 | – | 190,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|